Larkspur Biosciences to Participate in the 2023 BIO International Convention
May 30, 2023 08:00 ET
|
Larkspur Biosciences, Inc.
WATERTOWN, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a biotechnology company building the next precision immunotherapies to outsmart cancer, announced that they will be...
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
May 23, 2023 05:30 ET
|
Larkspur Biosciences, Inc.
Addressing the Key Bottlenecks in the Tumor Microenvironment That Allow a Tumor to Subvert the Immune System Financing Co-led by Polaris Innovation Fund, 3E Bioventures Capital, and Takeda...